Annals of internal medicine
-
Comment Meta Analysis
In patients with type 2 diabetes or HF, SGLT2 inhibitors reduce gout-related outcomes.
Banerjee M, Pal R, Maisnam I, et al. Serum uric acid lowering and effects of sodium-glucose cotransporter-2 inhibitors on gout: a meta-analysis and meta-regression of randomized controlled trials. Diabetes Obes Metab. 2023;25:2697-2703. 37334516.